These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32747344)

  • 1. Can β2-agonists have an ergogenic effect on strength, sprint or power performance? Systematic review and meta-analysis of RCTs.
    Riiser A; Stensrud T; Stang J; Andersen LB
    Br J Sports Med; 2020 Nov; 54(22):1351-1359. PubMed ID: 32747344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerobic performance among healthy (non-asthmatic) adults using beta2-agonists: a systematic review and meta-analysis of randomised controlled trials.
    Riiser A; Stensrud T; Stang J; Andersen LB
    Br J Sports Med; 2021 Sep; 55(17):975-983. PubMed ID: 32816795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β₂-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials.
    Pluim BM; de Hon O; Staal JB; Limpens J; Kuipers H; Overbeek SE; Zwinderman AH; Scholten RJ
    Sports Med; 2011 Jan; 41(1):39-57. PubMed ID: 21142283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
    Kindermann W
    Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
    Wolfarth B; Wuestenfeld JC; Kindermann W
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined inhalation of beta2 -agonists improves swim ergometer sprint performance but not high-intensity swim performance.
    Kalsen A; Hostrup M; Bangsbo J; Backer V
    Scand J Med Sci Sports; 2014 Oct; 24(5):814-22. PubMed ID: 23834392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled beta2 agonists and performance in competitive athletes.
    Kindermann W; Meyer T
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i43-7. PubMed ID: 16799103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews.
    Craig SS; Dalziel SR; Powell CV; Graudins A; Babl FE; Lunny C
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012977. PubMed ID: 32767571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta2-Agonist Doping Control and Optical Isomer Challenges.
    Jacobson GA; Fawcett JP
    Sports Med; 2016 Dec; 46(12):1787-1795. PubMed ID: 27164986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anabolic and lipolytic actions of beta
    Hostrup M; Jacobson GA; Jessen S; Lemminger AK
    Drug Test Anal; 2020 May; 12(5):597-609. PubMed ID: 31960603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute supra-therapeutic oral terbutaline administration has no ergogenic effect in non-asthmatic athletes.
    Sanchez AM; Borrani F; Le Fur MA; Le Mieux A; Lecoultre V; Py G; Gernigon C; Collomp K; Candau R
    Eur J Appl Physiol; 2013 Feb; 113(2):411-8. PubMed ID: 22767151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma.
    Travers AH; Jones AP; Camargo CA; Milan SJ; Rowe BH
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010256. PubMed ID: 23235686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma.
    Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terbutaline: level the playing field for inhaled β
    Jacobson GA; Hostrup M
    Br J Sports Med; 2017 Sep; 51(18):1323-1324. PubMed ID: 27461883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
    Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
    Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute and 2-week administration of oral salbutamol on exercise performance and muscle strength in athletes.
    Hostrup M; Kalsen A; Auchenberg M; Bangsbo J; Backer V
    Scand J Med Sci Sports; 2016 Jan; 26(1):8-16. PubMed ID: 25077918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formoterol concentrations in blood and urine: the World Anti-Doping Agency 2012 regulations.
    Eibye K; Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
    Med Sci Sports Exerc; 2013 Jan; 45(1):16-22. PubMed ID: 22843108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids and physical performance: A systematic review with meta-analysis of randomized controlled trials.
    Riiser A; Stensrud T; Andersen LB
    Front Sports Act Living; 2023; 5():1108062. PubMed ID: 37033881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond bronchodilation: Illuminating the performance benefits of inhaled beta
    Hostrup M; Jessen S
    Scand J Med Sci Sports; 2024 Jan; 34(1):e14567. PubMed ID: 38268072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.